Sage Journals: Discover world-class research

Free access

Research article

First published 2012-1

Effects of pioglitazone and metformin on vascular endothelial function in patients with type 2 diabetes treated with sulfonylureas

Katerina K Naka, Katerina Papathanassiou, Aris Bechlioulis [...]

Diabetes & Vascular Disease Research

Retricted access

Research article

First published 2013-10

Pioglitazone Decreases Asymmetric Dimethylarginine Levels in Patients with Impaired Glucose Tolerance or Type 2 Diabetes

Nobuhiro Tahara, Sho-ichi Yamagishi, Minori Mizoguchi [...]

Rejuvenation Research

Retricted access

Research article

First published 2013-7

Design of a Prospective,Dose-Escalation Study Evaluating the Safety of Pioglitazone for Hematoma Resolution in Intracerebral Hemorrhage (SHRINC)

Nicole R. Gonzales, Jharna Shah, Navdeep Sangha [...]

International Journal of Stroke

Retricted access

Research article

First published 2017-1

Reporting on Adverse Clinical Events

Clin-Alert

Retricted access

Brief report

First published 2012-10

Effect of Insulin versus Triple Oral Therapy on the Progression of Hepatic Steatosis in Type 2 Diabetes

Ildiko Lingvay, Erin D. Roe, Jonathan Duong [...]

Journal of Investigative Medicine

Free access

Research article

First published 2011-7

Effect of Pioglitazone and Ramipril on Biomarkers of Low-Grade Inflammation and Vascular Function in Nondiabetic Patients with Increased Cardiovascular Risk and an Activated Inflammation: Results from the PIOace Study

Andreas Pfützner, Markolf Hanefeld, Lida A. Dekordi [...]

Journal of Diabetes Science and Technology

Retricted access

Research article

First published 2007-7

Oral Antidiabetic Agents in Pregnancy and Lactation: A Paradigm Shift?

Denice S Feig, Gerald G Briggs, Gideon Koren

Annals of Pharmacotherapy

Search results

Effects of pioglitazone and metformin on vascular endothelial function in patients with type 2 diabetes treated with sulfonylureas

Pioglitazone Decreases Asymmetric Dimethylarginine Levels in Patients with Impaired Glucose Tolerance or Type 2 Diabetes

Design of a Prospective,Dose-Escalation Study Evaluating the Safety of Pioglitazone for Hematoma Resolution in Intracerebral Hemorrhage (SHRINC)

Reporting on Adverse Clinical Events

Effect of Insulin versus Triple Oral Therapy on the Progression of Hepatic Steatosis in Type 2 Diabetes

Effect of Pioglitazone and Ramipril on Biomarkers of Low-Grade Inflammation and Vascular Function in Nondiabetic Patients with Increased Cardiovascular Risk and an Activated Inflammation: Results from the PIOace Study

Oral Antidiabetic Agents in Pregnancy and Lactation: A Paradigm Shift?